Canopy Growth Corporation (CGC) vs Tilray Brands, Inc. (TLRY)

Canopy Growth Corporation and Tilray Brands, Inc. are both Drug Manufacturers Specialty & Generic companies. Tilray Brands, Inc. is the larger, with a market value of $603.0M against $397.7M — 1.5× the size. Tilray Brands, Inc. grew revenue faster over the last twelve months: 11.5% against 7.80%. Tilray Brands, Inc. has the higher net margin (−13.3% vs −80.4%) and the higher return on invested capital (−2.27% vs −17.2%). Across the 18 metrics below, Tilray Brands, Inc. leads on 15 and Canopy Growth Corporation on 3.

Valuation

Metric CGC TLRY Drug Manufacturers Specialty & Generic median
P/E n/m n/m 20.14
P/S 1.87 0.50 2.25
P/B 0.80 0.29 1.90
Price to free cash flow n/m n/m 16.54
EV/EBITDA n/m 48.33 12.29
EV/Sales 1.52 0.66 2.56
Earnings yield (47.27%) (26.15%) (2.99%)
Free cash flow yield (15.29%) (32.87%) 0.00%

Profitability

Metric CGC TLRY Drug Manufacturers Specialty & Generic median
Gross margin 25.16% 28.45% 53.94%
Operating margin (54.89%) (6.88%) 0.00%
Net margin (80.39%) (13.26%) 0.00%
Free cash flow margin (28.34%) (10.77%) 0.00%
Return on equity (40.14%) (7.87%) (0.40%)
Return on assets (23.54%) (5.52%) (3.32%)
Return on invested capital (17.19%) (2.27%) 0.00%

Growth

Metric CGC TLRY Drug Manufacturers Specialty & Generic median
Revenue growth (TTM) 7.80% 11.46% 10.01%
EPS growth (last fiscal year) 84.00% 95.57% —
Revenue growth, 5-year CAGR (13.04%) 7.82% 6.74%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric CGC TLRY Drug Manufacturers Specialty & Generic median
Debt to equity 0.35 0.24 0.05
Current ratio 3.04 2.21 2.31
Net debt to EBITDA 1.09 11.34 0.85

Dividend

Metric CGC TLRY Drug Manufacturers Specialty & Generic median
Dividend yield — — 1.70%
Payout ratio 0.00 0.00 0.00

Size

Metric CGC TLRY Drug Manufacturers Specialty & Generic median
Market cap 397.66m 602.95m 337.35m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack